Monthly intra-individual variation in lipoprotein(a) in 22 normal subjects over 12 months

Clinical Biochemistry

Volumn 30, Issue 2, 1997, Pages 163-170

  Nazir, Darius J ^a   McQueen, Matthew J ^b  

^a HAMILTON HEALTH SCIENCES   (Canada)

^b NONE

Author keywords

lipoprotein(a); Lp(a) levels in normal subjects; monthly Lp(a) fluctuations

Indexed keywords

LIPOPROTEIN A;

ADULT; ANTIBODY SPECIFICITY; ARTICLE; CLINICAL ARTICLE; CORONARY RISK; DRUG BLOOD LEVEL; FEMALE; HUMAN; INDIVIDUALIZATION; ISCHEMIC HEART DISEASE; LIPID COMPOSITION; LIPOPROTEIN METABOLISM; MALE; OBSERVER VARIATION; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

ADULT; FEMALE; HUMANS; LIPOPROTEIN(A); MALE; MIDDLE AGED; PRECIPITIN TESTS; REFERENCE VALUES; TIME FACTORS;

EID: 0030890752     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(96)00163-4     Document Type: Article

References (41)

1. Berg K. A new serum type system in man. The Lp system. Acta Pathol Microbiol Scand 1963; 59: 369-82.
2. Scanu, AM. Structural and functional polymorphism of lipoprotein(a). Biological and clinical implications. Clin Chem 1995; 41: 170-72.
3. White AL, Rainwater DL, Hixson JE, Estlack LE, Lanford RE. Intracellular processing of apo(a) in primary baboon hepatocytes. In: Paltauf F, Schmid HHO, Eds. Chemistry and Physics of Lipids Shannon: Elsevier, 1994; 67/68: 122-33.
4. Blanco-Vaca F, Gaubatz JW, Bren N, Kottke BA, Morrisett JD, Guevara J Jr. Identification and quantification of apolipoproteins in addition to apo(a) and apo B-IOO in human lipoprotein (a). In: Paltauf F, Schmid HHO, Eds. Chemistry and Physics of Lipids 1994. Shannon; Elsevier, 67/68: 35-42.
5. Sines J, Rothnagel R, van Heel M, Gaubatz JW, Morrisett JD, Chiu, W. Electron cryomicroscopy and digital image processing of lipoprotein(a). In: Paltauf F, Schmid HHO, Eds Chemistry and Physics of Lipids. Shannon: Elsevier, 1994; 67/68: 81-89.
6. Lawn RM. The apoliproprotein(a) gene: characterization of 5′ flanking regions and expression in transgenic mice. In: Paltauf F, Schmid HHO, Eds. Chemistry and Physics of Lipids, Shannon:Elsevier, 1994; 67/68: 19-23.
7. Rhoads GG, Dahlen G, Berg K, Morton NE, Dannenberg AL. Lp(a) lipoprotein as a risk factor for myocardial infarction. JAMA 1986; 256: 2540-44.
8. Rosengren A, Wilhemsen L, Eriksson E, Risberg B, Wedel H. Lipoprotein(a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men. Br Med J 1990; 301: 1248-51.
9. White AL, Rainwater DL, Hixson JE, Estlack LE, Landford RE. Intracellular processing of apo(a) in primary baboon hepatocytes. In: Paltauf F, Schmid HHO, Eds. Chemistry and Physics of Lipids, Shannon: Elsevier, 1994; 67/68: 123-33.
10. McConathy WJ, Trieu VN, Koren E, Wange C-S, Corder CC. Triglyceride-rich lipoprotein interactions with Lp(a). In: Paltauf F, Schmid HHO, Eds. Chemistry and Physics of Lipids. Shannon: Elsevier, 1994; 67/68: 105-13.
11. Ponjee GAE, Janssen EME, van Wersch JWJ. Long term physical exercise and lipoprotein(a) levels in a previously sedentary male and female population. Ann Clin Biochem 1995; 32: 181-85.
12. Parra HJ, Luyéyé I, Bouramoué C, Demarquilly C, Fruchart JC. Black-white differences in serum Lp(a) lipoprotein levels. Clin Chim Acta 1987; 168: 27-31.
13. Levitsky LL, Scanu AM, Gould SH. Lipoprotein(a) levels in black and white children and adolescents with IDDM. Diabetes Care 1991; 14: 283-87.
14. Sandholzer C, Hallman DM, Saha N, Sigurdsson G, Lackner C, Császár A, et al. Effects of the apolipoprotein(a) size polymorphism on the lipoprotein(a) concentration in 7 ethnic groups. Hum Genet 1991; 86: 607-14.
15. Boerwinkle E, Leffert CC, Lin J, Lackner C, Chiesa G, Hobbs HH. Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J Clin Invest 1992; 90: 52-60.
16. Albers JJ, Adolphson JL, Hazzard WR. Radioimmunoassay of human plasma Lp(a) lipoprotein. J Lipid Res 1977; 18: 331-38.
17. Scanu AM. Genetic basis and pathophysiological implications of high plasma Lp(a) levels. J Intern Med 1992; 231: 679-83.
18. Scanu AM, Lawn RM, Berg K. Lipoprotein(a) and atherosclerosis. Ann Intern Med 1991; 115: 209-18.
19. Slunga L, Asplund K, Johnson O, Dahlén GH. Lipoprotein(a) in a randomly selected 25-64-year-old population: The Northern Sweden MONICA study. J Clin Epidemiol 1993; 46: 617-24.
20. Brown SA, Hutchinson R, Morrisett J, et al. Plasma lipids, lipoprotein cholesterol and apoprotein distributions in selected US communities. Arterio & Thromb. 1993; 13: 1139-58.
21. Jenner JL, Ordovas JM, Lamon-Fava S, et al. Effects of age, sex and menopausal status on plasma lipoprotein(a) levels: The Framingham Offspring Study. Circulation 1993; 87: 1135-41.
22. Davies M, Rayman G, Day J. Increased incidence of coronary disease in people with impaired glucose tolerance: Link with increased lipoprotein(a) concentrations. Br Med J 1992; 304: 1610-11.
23. Nakata H, Horita K, Eto M. Alteration of lipoprotein(a) concentration with glycemic control in non-insulin dependent diabetic subjects without diabetic complications. Metabolism 1993; 42: 1323-26.
24. Folson AR, Wu KK, Davis CE, Conlan MG, Sorbie PD, Szklo M. Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. Atherosclerosis 1991; 91: 191-205.
25. Heinrich J, Sandkamp M, Kokott R, Schulte H, Assmann G. Relationship of lipoprotein(a) to variables of coagulation and fibrinolysis in a healthy population. Clin Chem 1991; 37: 1950-54.
26. Karádl I, Romics L, Pálos G et al. Lp(a) lipoprotein concentration in serum of patients with heavy proteinurea of different origin. Clin Chem 1989; 35: 2121-23.
27. Shen GX, Mymin D, Dembinski T, Krahn A, Angel A. Polymorphism and peripheral levels of apolipoprotein(a) in polygenic hypercholesterolemia and combined hyperlipidemia. Clin Invest Med 1995; 18: 33-41.
28. Gaw A, Boerwinkle E, Cohen JC, Hobbs HH. Comparative analysis of the apo(a) gene, apo(a) glycoprotein and plasma concentrations of Lp(a) in three ethnie groups. J Clin Invest 1994; 93: 2526-34.
29. Parra HJ, Mezdour H, Cachera C, Dracon M, Tacquet A, Fruchart JC. Lp(a) lipoprotein in patients with chronic renal failure treated by hemodialysis. Clin Chem 1987; 33: 721.
30. Oida K, Takai H, Maeda H, et al. Apolipoprotein(a) is present in urine and its excretion is decreased in patients with renal failure. Clin Chem 1992; 38: 2244-48.
31. Dieplinger H, Lackner C, Kronenberg F, et al. Elevated plasma concentrations of lipoprotein(a) in patients with end stage renal disease are not related to the size polymorphism of apolipoprotein(a). J Clin Invest 1993; 91: 397-401.
32. Panteghini M, Pagani F. Pre-analytical, analytical and biological sources of variation of lipoprotein(a). Eur J Clin Chem Clin Biochem 1993; 31: 23-28.
33. Nazir DJ, McQueen MJ. Monthly variations in Lp(a) concentrations in free-living normal subjects. Clin Biochem 1995; 28: 323. Abstract.
34. Kleinbaum DG, Kupper LL, Muller KE. Applied regression analyses and other multivariable methods. Boston: PWS-Kent, 1988; 341-361.
35. Kleinbaum DG, Kupper LL, Muller KE. Applied regression analyses and other multivariable methods. Boston: PWS-Kent, 1988; 457-472.
36. Van Wersch JWJ. The behavior of lipoprotein(a) in patients with various diseases. Scan J Clin Lab Invest 1994; 54: 559-62.
37. Labeur C, De Bacquer D, De Backer G, et al. Plasma lipoprotein(a) values and severity of coronary artery disease in a large population of patients undergoing coronary angiography. Clin Chem 1992; 38: 2261-6.
38. Scanu AM. Lipoprotein(a). A genetic risk factor for premature coronary heart disease. JAMA 1992; 267: 3326-26.
39. Pokrovsky SN, Sussekov AV, Afanasieva OI, Adamova IY, Lyakishev AA, Kukharchuk VV. Extracorporeal immunoabsorption for the specific removal of lipoprotein(a) (Lp(a) apheresis): preliminary clinical data. In: Paltauf F, Schmid HHO, Eds. Chemistry and Physics of Lipids. Shannon: Elsevier, 1994; 67/68: 323-30.
40. Marcovina SM, Gaur VP, Albers JJ. Biological variability of cholesterol, triglyceride, low- and high-density lipoprotein cholesterol, lipoprotein(a), and apolipoproteins A-1 and B. Clin Chem 1994; 40: 574-78.
41. Mackness MI, Bhatnagar D, Weiringa GM, MBewu A, Haynes B and Durrington PN. A comparative study of six commercial lipoprotein(a) assays in seventeen laboratories within the British Isles. Ann Clin Biochem 1996; 33: 63-70.